Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Ginkgo Bioworks Holdings IncTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Neurocrine Biosciences Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Neurocrine Biosciences Inc trades at $151.32 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 32.5× Ginkgo Bioworks Holdings Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.

DNANBIX
Market Cap
$505.73M$16.46B
Sector
HealthHealth
52-Week High
$16.14$185.50
52-Week Low
$5.48$123.10
Enterprise Value
$607.68M$16.48B

Returns comparison

Trailing returns across standard periods

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX